Back to News
Market Impact: 0.35
Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff
Source: 247wallst.com
Corporate EarningsCorporate Guidance & Outlook
Johnson & Johnson shares were down 5% early in the session at $249.55. The company raised its full-year outlook, while reported profit fell under one-time charges; the article provides no figures for either change.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment
JNJ0.10
More News
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
- Meta shares rise for a second straight day as new AI model family impresses
- J&J beats earnings estimates; Middle East conflict weighs on medical-device sales
- Wall St edges lower as chips fall; markets assess big bank earnings
- Wall Street Banks Face New Pressure
- Johnson & Johnson shares SLIDE nearly 6% despite stronger full-year forecast